Industry Trends

January 2021

See what has been happening in Asia’s pharma and personal care industries over the last weeks. What are experts and industry magazines talking about?

What has been happening?

SEA oral care segment, Marijuana in meals and cosmetics, China allow use of nano and biotech materials in cosmetics and more. See what journals and industry experts have been discussing in the last four weeks.

Latest Industry Articles

Under tapped SEA oral care segment holds ‘most potential’
CosmeticsDesign-Asia

New Zealand-based oral care brand ukiwi is setting its sights on South East Asia, which it believes holds the most untapped potential for ‘new and innovative’ players.
Thailand to promote use of marijuana in meals, cosmetics
NST Online

THAILAND plans to promote the use of marijuana in meals and cosmetics as the nation tries to lure foreign tourists as the demand for legal cannabis grows.
China ready to allow use of nano and biotech materials in cosmetics for the first time
CosmeticsDesign-Asia

China is allowing the use of nano and biotechnology materials in cosmetic products for the first time, offering tremendous opportunities for new enterprises and products.
Oxford research tackles threat of antibiotic resistance
BBC News

Oxford says the “public cannot get enough of experts” with a £100m donation for antibiotics research.
One-hour delivery services for cosmetics the new ‘habit’ in China – Dada Group
CosmeticsDesign-Asia

Chinese on-demand retail and delivery firm Dada Group is working to expand its beauty category in 2021 to keep up with consumer need for quick and speedy delivery services.
China's PD-1 coverage; Fujifilm's $2B U.S. expansion; Sinopharm COVID-19 vaccine data
FiercePharma News

Fierce Pharma Asia—China’s PD-1 coverage; Fujifilm’s $2B U.S.
AB Science announces that a new independent publication confirms that masitinib has anti-vital activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating Covid-19
GlobeNewswire

NEW INDEPENDENT PUBLICATION CONFIRMS THAT MASITINIB HAS ANTI-VIRAL ACTIVITY AGAINST THE SARS-COV-2 VIRUS IN VITRO AND IS A PROMISING CANDIDATE FOR TREATING COVID-19.
Holy Name Medical Center in Teaneck, New Jersey Acquires Sensus Healthcare’s Low-dose Radiation Therapy System to Treat Pneumonia in COVID-19 Patients

GlobeNewswire

Sensus Healthcare, Inc., a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced Holy Name Medical Center in Teaneck, New Jersey has acquired a Sensus low-dose radiation therapy system for the treatment of pneumonia in COVID-19 patients.

Petronas Said to Enter Fray for $4 Billion Lonza Chemicals Unit
Bloomberg

Malaysian state oil producer Petroliam Nasional Bhd. is among suitors vying for a chemicals business being sold by Lonza Group AG, people with knowledge of the situation said.
Lonza to sell 2 plants to NextPharma as it plows ahead with $93M capsule expansion
FiercePharma News

Lonza is hammering out a deal to sell off a pair of sites in Ploermel, France and Edinburgh, Scotland to British CDMO NextPharma. Both sites produce lipid oral-dose drugs as liquid-filled hard capsules and softgels.
FDA approves China’s Clover Pharmaceuticals clinical trial in Phl

Daily Tribune

The Food and Drug Administration (FDA) that it has given its approval to Chinese firm Clover Pharmaceuticals to conduct a COVID-19 vaccine clinical trial in the country.
With this, there are now two vaccine firms that will be holding a trial. Aside from Clover Pharmaceuticals, the FDA approved the clinical trial of Belgian company Janssen Pharmaceuticals.

Related Articles & Trends

Pharma & Personal Care Trends – November 2024

Pharma & Personal Care Trends – November 2024

Beauty 4.0: The state of the menopausal beauty market, New skin care line to address surging interest in Traditional Chinese Medicine and well-being, Benefits of transitioning to E-Cigarettes, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – October 2024

Pharma & Personal Care Trends – October 2024

Sustainable cosmetic packaging innovations at Luxe Pack 2024, One or two-dose HPV vaccination, 3 ways to maintain glowy skin, and more. See what industry experts have been discussing in the last four weeks.

Pharma & Personal Care Trends – September 2024

Pharma & Personal Care Trends – September 2024

Rutin emerges as a sustainable alternative in sunscreen formulations, Infusing sustainability and transparency into skin care, Formulating menopausal skin care, and more. See what industry experts have been discussing in the last four weeks.

Industry News . Once a month . No spam